Renaissance Technologies - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 61 filers reported holding GALENA BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q4 2017$828,000
-15.3%
3,160,286
+14.1%
0.00%0.0%
Q3 2017$977,000
-24.3%
2,769,786
+24.7%
0.00%
-50.0%
Q2 2017$1,290,000
+32.2%
2,221,086
+38.8%
0.00%
+100.0%
Q1 2017$976,0001,600,2750.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
EQUITEC SPECIALISTS, LLC 358,600$696,0000.17%
ARXIS SECURITIES LLC 13,039$25,0000.03%
EQUITEC SPECIALISTS, LLC 65,600$127,0000.03%
Acrospire Investment Management LLC 13,100$25,0000.01%
Virtu KCG Holdings LLC 60,313$117,0000.00%
INTEGRAL DERIVATIVES, LLC 72,200$140,0000.00%
SABBY MANAGEMENT, LLC 23,298$45,0000.00%
WOLVERINE TRADING, LLC 229,400$445,0000.00%
Tower Research Capital LLC (TRC) 10,339$20,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,030,800$2,000,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders